APOA2 Antikörper (HRP)
Kurzübersicht für APOA2 Antikörper (HRP) (ABIN7449328)
Target
Alle APOA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Goat anti-Human Apo AII [H04] Antibody HRP Conjugated
-
Immunogen
- Human Apolipoprotein AII
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:1,000 - 1:8,000
ELISA: 1:1,000 - 1:8,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- 50 mM PBS, 0.1 M NaCl, and 0.01 % Thiomersal, pH 7.4
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- APOA2 (Apolipoprotein A-II (APOA2))
-
Andere Bezeichnung
- ApoAII
-
Hintergrund
- Background: Apo AII comprises 25 % of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993), however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events. (Birjmohun et al., 2007)
-
Gen-ID
- 336
-
NCBI Accession
- NP_001634
-
UniProt
- P02652
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Target
-